Cell adhesion molecules and their relation to (cancer) cell stemness.

Despite decades of search for anticancer drugs targeting solid tumors, this group of diseases remains largely incurable, especially if in advanced, metastatic stage. In this review, we draw comparison between reprogramming and carcinogenesis, as well as between stem cells (SCs) and cancer stem cells (CSCs), focusing on changing garniture of adhesion molecules. Furthermore, we elaborate on the role of adhesion molecules in the regulation of (cancer) SCs division (symmetric or asymmetric), and in evolving interactions between CSCs and extracellular matrix. Among other aspects, we analyze the role and changes of expression of key adhesion molecules as cancer progresses and metastases develop. Here, the role of cadherins, integrins, as well as selected transcription factors like Twist and Snail is highlighted, not only in the regulation of epithelial-to-mesenchymal transition but also in the avoidance of anoikis. Finally, we briefly discuss recent developments and new strategies targeting CSCs, which focus on adhesion molecules or targeting tumor vasculature.

[1]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.

[2]  A. Rossi,et al.  The role of antiangiogenetic agents in the treatment of breast cancer. , 2011, Current Medicinal Chemistry.

[3]  D. Radisky,et al.  Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development , 2008, Clinical & Experimental Metastasis.

[4]  Ido Amit,et al.  Regulation of MAPKs by growth factors and receptor tyrosine kinases. , 2007, Biochimica et biophysica acta.

[5]  G. Berx,et al.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.

[6]  Ajit Varki,et al.  Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Klein,et al.  Chromosomal rearrangements after ex vivo Epstein–Barr virus (EBV) infection of human B cells , 2010, Oncogene.

[8]  D. Rifkin,et al.  Making sense of latent TGFbeta activation. , 2003, Journal of cell science.

[9]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[10]  Guang-Jer Wu Dual Roles of METCAM in the Progression of Different Cancers , 2012, Journal of oncology.

[11]  F. Sotgia,et al.  Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells , 2011, Cancer biology & therapy.

[12]  G. Prud’homme Cancer stem cells and novel targets for antitumor strategies. , 2012, Current pharmaceutical design.

[13]  Houjie Liang,et al.  Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells , 2011, Clinical & Experimental Metastasis.

[14]  Hsu-hsin Chen,et al.  The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells , 2008, Cell.

[15]  D. Scadden,et al.  The stem-cell niche as an entity of action , 2006, Nature.

[16]  R. Kaplan,et al.  Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond , 2007, Cancer and Metastasis Reviews.

[17]  W. Birchmeier,et al.  New aspects of Wnt signaling pathways in higher vertebrates. , 2001, Current opinion in genetics & development.

[18]  M. Fraga,et al.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.

[19]  O. Cinquin Purpose and regulation of stem cells: a systems‐biology view from the Caenorhabditis elegans germ line , 2009, The Journal of pathology.

[20]  B. Gumbiner,et al.  Regulation of Cadherin Adhesive Activity , 2000, The Journal of cell biology.

[21]  S. Roura,et al.  Regulation of E-cadherin/catenin association by tyrosine phosphorylation. , 2016, The Journal of Biological Chemistry.

[22]  E. Nishida,et al.  PtdIns(3,4,5)P3 regulates spindle orientation in adherent cells. , 2007, Developmental cell.

[23]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[24]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[25]  Mustapha Kandouz,et al.  Gap junctions and connexins as therapeutic targets in cancer , 2010, Expert opinion on therapeutic targets.

[26]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[27]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.

[28]  S. Islam,et al.  Attributes of adult stem cells , 2009, The Journal of pathology.

[29]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Wicha,et al.  Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia , 2012, Proceedings of the National Academy of Sciences.

[31]  F. Shojaei,et al.  Anti-angiogenesis therapy in cancer: current challenges and future perspectives. , 2012, Cancer letters.

[32]  Maria Athelogou,et al.  Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  R. Kalluri Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[34]  W. Sadee,et al.  ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. , 2005, Cancer research.

[35]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[36]  Charles H. Graham,et al.  Hypoxia-driven selection of the metastatic phenotype , 2007, Cancer and Metastasis Reviews.

[37]  F. Luscinskas,et al.  Integrins as dynamic regulators of vascular function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  J. Medema,et al.  Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame? , 2013, Cancer letters.

[39]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[40]  Y. Samstag,et al.  High affinity interaction of integrin α4β1 (VLA‐4) and vascular cell adhesion molecule 1 (VCAM‐1) enhances migration of human melanoma cells across activated endothelial cell layers , 2007, Journal of cellular physiology.

[41]  Sean J. Morrison,et al.  Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life , 2008, Cell.

[42]  J. Serody,et al.  Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2 , 2013, The Journal of Immunology.

[43]  W. Birchmeier,et al.  E‐cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming , 2011, EMBO reports.

[44]  H. Ji,et al.  Vertebrate development requires ARVCF and p120 catenins and their interplay with RhoA and Rac , 2004, The Journal of cell biology.

[45]  M. Ratajczak,et al.  The role of stromal-derived factor-1--CXCR7 axis in development and cancer. , 2009, European journal of pharmacology.

[46]  E. Wurmbach,et al.  Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis , 2006, Leukemia.

[47]  W. Nacken,et al.  Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.

[48]  M. Los,et al.  An efficient approach for the isolation, identification and evaluation of antimicrobial plant components on an analytical scale, demonstrated by the example of Radix imperatoriae , 2010, Analytical and bioanalytical chemistry.

[49]  K. Lam,et al.  Molecular Imaging of Very Late Antigen–4 (α4β1 Integrin) in the Premetastatic Niche , 2012, The Journal of Nuclear Medicine.

[50]  K. Anderson,et al.  p38 and a p38-Interacting Protein Are Critical for Downregulation of E-Cadherin during Mouse Gastrulation , 2006, Cell.

[51]  E. Fuchs,et al.  Catenins: keeping cells from getting their signals crossed. , 2006, Developmental cell.

[52]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[53]  Gordon B. Mills,et al.  Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity* , 2007, Journal of Biological Chemistry.

[54]  H. Kowalczyńska,et al.  Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions , 2012, Cell biology international.

[55]  S. Hanks,et al.  Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Monica Boyle,et al.  Decline in self-renewal factors contributes to aging of the stem cell niche in the Drosophila testis. , 2007, Cell stem cell.

[57]  D. Sheppard,et al.  Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. , 2011, Cold Spring Harbor perspectives in biology.

[58]  M. Mattson,et al.  β1 Integrin Maintains Integrity of the Embryonic Neocortical Stem Cell Niche , 2009, PLoS biology.

[59]  O. Blaschuk,et al.  Cadherins as Modulators of Angiogenesis and the Structural Integrity of Blood Vessels , 2004, Cancer and Metastasis Reviews.

[60]  M. Takeichi Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[61]  David García-Dorado,et al.  TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.

[62]  Dean Sheppard,et al.  Integrin-mediated activation of latent transforming growth factor β , 2005, Cancer and Metastasis Reviews.

[63]  H. Deng,et al.  MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. , 2007, Differentiation; research in biological diversity.

[64]  Justin P. Annes,et al.  Making sense of latent TGFβ activation , 2003, Journal of Cell Science.

[65]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[66]  Y. Ono,et al.  MAGI1 Recruits Dll1 to Cadherin-based Adherens Junctions and Stabilizes It on the Cell Surface* , 2005, Journal of Biological Chemistry.

[67]  Jing Wen,et al.  CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cells , 2009, International journal of cancer.

[68]  L. Borsig,et al.  Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins , 2012, International journal of cell biology.

[69]  Kohei Miyazono,et al.  Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[70]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[71]  E. Wiechec Implications of genomic instability in the diagnosis and treatment of breast cancer , 2011, Expert review of molecular diagnostics.

[72]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[73]  K. Schulze-Osthoff,et al.  Cancer stem cells as targets for cancer therapy: selected cancers as examples , 2008, Archivum Immunologiae et Therapiae Experimentalis.

[74]  L. Larue,et al.  Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.

[75]  M. Glukhova,et al.  Adhesion within the stem cell niches. , 2009, Current opinion in cell biology.

[76]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[77]  Wareef Kabbani,et al.  Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis , 2010, Proceedings of the National Academy of Sciences.

[78]  G. Berx,et al.  The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.

[79]  Jialiang Liang,et al.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.

[80]  E. Fuchs,et al.  Epidermal homeostasis: a balancing act of stem cells in the skin , 2009, Nature Reviews Molecular Cell Biology.

[81]  C. Wiuf,et al.  High-Resolution Melting Analysis for Mutation Screening of RGSL1, RGS16, and RGS8 in Breast Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[82]  P. Stern,et al.  E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells. , 2007, Molecular biology of the cell.

[83]  Max S Wicha,et al.  HER2 and breast cancer stem cells: more than meets the eye. , 2013, Cancer research.

[84]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[85]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[86]  Harikrishna Nakshatri,et al.  CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.

[87]  A. Mahowald,et al.  Asymmetric Inheritance of Mother Versus Daughter Centrosome in Stem Cell Division , 2007, Science.

[88]  R. Juliano,et al.  Integrin Signaling , 2005, Cancer and Metastasis Reviews.

[89]  L. Hansen,et al.  A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas , 2008, Genes, chromosomes & cancer.

[90]  K. Csiszȧr,et al.  Cellular Fibronectin Binds to Lysyl Oxidase with High Affinity and Is Critical for Its Proteolytic Activation* , 2005, Journal of Biological Chemistry.

[91]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[92]  G. Tanentzapf,et al.  Integrin-mediated adhesion and stem-cell-niche interactions , 2009, Cell and Tissue Research.

[93]  D. Stupack,et al.  A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. , 2006, The Journal of clinical investigation.

[94]  R Kemler,et al.  A role for cadherins in tissue formation. , 1996, Development.

[95]  Timothy A. Springer,et al.  The dynamic regulation of integrin adhesiveness , 1994, Current Biology.

[96]  G. Semenza Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[97]  B. Futscher Epigenetic changes during cell transformation. , 2013, Advances in experimental medicine and biology.

[98]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[99]  K. Flaherty,et al.  Targeting the RAS pathway in melanoma. , 2012, Trends in molecular medicine.

[100]  B. Gumbiner,et al.  Regulation of cadherin-mediated adhesion in morphogenesis , 2005, Nature Reviews Molecular Cell Biology.

[101]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[102]  Ting Xie,et al.  Differentiation-defective stem cells outcompete normal stem cells for niche occupancy in the Drosophila ovary. , 2008, Cell stem cell.

[103]  P. Stern,et al.  Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. , 2007, Cancer research.

[104]  S. Butz,et al.  An alpha-E-catenin gene trap mutation defines its function in preimplantation development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[105]  P. Casey,et al.  beta-Catenin is a Nek2 substrate involved in centrosome separation. , 2008, Genes & development.

[106]  R L Juliano,et al.  Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. , 2002, Annual review of pharmacology and toxicology.

[107]  S. Weed,et al.  Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement , 2000, Oncogene.

[108]  M. Los New, exciting developments in experimental therapies in the early 21st century. , 2009, European journal of pharmacology.

[109]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[110]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[111]  W. Janzen,et al.  High Throughput Screening , 2016, Methods in Molecular Biology.

[112]  F. D. Houghton,et al.  Role of gap junctions during early embryo development. , 2005, Reproduction.

[113]  U. Cavallaro,et al.  The functional role of cell adhesion molecules in tumor angiogenesis. , 2009, Seminars in cancer biology.

[114]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[115]  D. Besser Expression of Nodal, Lefty-A, and Lefty-B in Undifferentiated Human Embryonic Stem Cells Requires Activation of Smad2/3* , 2004, Journal of Biological Chemistry.

[116]  P. McCrea,et al.  Developmental functions of the P120-catenin sub-family. , 2007, Biochimica et biophysica acta.

[117]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[118]  D. Peeper,et al.  Metastasis mechanisms. , 2009, Biochimica et biophysica acta.

[119]  K. Schulze-Osthoff,et al.  Cancer stem cell markers in common cancers - therapeutic implications. , 2008, Trends in molecular medicine.

[120]  S. Cai,et al.  Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells , 2011, BMC Cancer.

[121]  Andreas Trumpp,et al.  The evolving concept of cancer and metastasis stem cells , 2012, The Journal of cell biology.

[122]  Douglas R Lowy,et al.  E‐cadherin‐mediated adhesion inhibits ligand‐dependent activation of diverse receptor tyrosine kinases , 2004, The EMBO journal.

[123]  X. Bian,et al.  Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis. , 2010, Journal of genetics and genomics = Yi chuan xue bao.

[124]  M. Frank,et al.  The therapeutic promise of the cancer stem cell concept. , 2010, The Journal of clinical investigation.

[125]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[126]  D. Leckband,et al.  Integrated biochemical and mechanical signals regulate multifaceted human embryonic stem cell functions , 2010, The Journal of cell biology.

[127]  D. Godt,et al.  Integrin-dependent anchoring of a stem-cell niche , 2007, Nature Cell Biology.

[128]  K. Gravdal,et al.  A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer , 2007, Clinical Cancer Research.

[129]  Masahiko Takemura,et al.  E‐cadherin prolongs the moment for interaction between intestinal stem cell and its progenitor cell to ensure Notch signaling in adult Drosophila midgut , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[130]  David A. Williams,et al.  Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling , 2008, Cell.

[131]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[132]  T. Brümmendorf,et al.  Identification of CD133−/Telomeraselow Progenitor Cells in Glioblastoma-Derived Cancer Stem Cell Lines , 2011, Cellular and Molecular Neurobiology.

[133]  V. Quaranta,et al.  Cadherin-Bound β-Catenin Feeds into the Wnt Pathway upon Adherens Junctions Dissociation: Evidence for an Intersection between β-Catenin Pools , 2009, PloS one.

[134]  Y. Kawai,et al.  MDA-MB-231 produces ATP-mediated ICAM-1-dependent facilitation of the attachment of carcinoma cells to human lymphatic endothelial cells. , 2008, American journal of physiology. Cell physiology.

[135]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[136]  O. Blaschuk,et al.  Cadherins as novel targets for anti-cancer therapy. , 2009, European journal of pharmacology.

[137]  Liwu Fu,et al.  Targeting cancer stem cells: a new therapy to cure cancer patients. , 2012, American journal of cancer research.

[138]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[139]  Ali H. Brivanlou,et al.  Signaling Pathways in Cancer and Embryonic Stem Cells , 2007, Stem Cell Reviews.

[140]  A. Russell,et al.  Abrogation of E‐Cadherin‐Mediated Cell–Cell Contact in Mouse Embryonic Stem Cells Results in Reversible LIF‐Independent Self‐Renewal , 2009, Stem cells.

[141]  A. Aplin,et al.  Integrin-Mediated Adhesion Regulates ERK Nuclear Translocation and Phosphorylation of Elk-1 , 2001, The Journal of cell biology.

[142]  L. Rozek,et al.  Cancer epigenetics: a brief review. , 2012, ILAR journal.

[143]  D. Larsimont,et al.  Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations , 2011, Oncogene.

[144]  S. Brooks,et al.  Molecular interactions in cancer cell metastasis. , 2010, Acta histochemica.

[145]  Gerhard Christofori,et al.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.

[146]  L. Zeef,et al.  E-Cadherin Acts as a Regulator of Transcripts Associated with a Wide Range of Cellular Processes in Mouse Embryonic Stem Cells , 2011, PloS one.

[147]  G. Camussi,et al.  Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. , 2011, Journal of the National Cancer Institute.

[148]  M. Fuller,et al.  Orientation of Asymmetric Stem Cell Division by the APC Tumor Suppressor and Centrosome , 2003, Science.

[149]  H. Moch,et al.  Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.

[150]  S. Mitalipov,et al.  Totipotency, pluripotency and nuclear reprogramming. , 2009, Advances in biochemical engineering/biotechnology.

[151]  M. O. oude Egbrink,et al.  The Role of Blood Platelets in Tumor Angiogenesis , 1985 .

[152]  J. Stetefeld,et al.  Modeling of Molecular Interaction between Apoptin, BCR-Abl and CrkL - An Alternative Approach to Conventional Rational Drug Design , 2012, PloS one.

[153]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[154]  M. Weller,et al.  Integrin control of the transforming growth factor-β pathway in glioblastoma. , 2013, Brain : a journal of neurology.

[155]  C. Damsky,et al.  Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. , 2000 .

[156]  M. Emi,et al.  Genome-wide copy number analysis in primary breast cancer , 2012, Expert opinion on therapeutic targets.

[157]  K. Syrigos,et al.  Cell Adhesion Molecules: Role and Clinical Significance in Cancer , 2009, Cancer investigation.

[158]  Yoshiki Sasai,et al.  Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states. , 2011, Trends in cell biology.

[159]  G. Gasparini,et al.  The paradigm of personalized therapy in oncology , 2012, Expert opinion on therapeutic targets.

[160]  T. Byzova,et al.  Platelets govern pre-metastatic tumor communication to bone , 2013, Oncogene.

[161]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[162]  R. Bajpai,et al.  Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. , 2008, Cancer research.

[163]  S. Panigrahi,et al.  Obesity: pathophysiology and clinical management. , 2009, Current medicinal chemistry.

[164]  Skin stem cells: rising to the surface , 2008 .

[165]  J. Herman,et al.  Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. , 2008, Cancer research.

[166]  Marek J. Łos,et al.  Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. , 2013, Biochimica et biophysica acta.

[167]  Jenny G. Parvani,et al.  Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β , 2013, Molecular biology of the cell.

[168]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[169]  C. Nguyên,et al.  Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[170]  K. Kimura,et al.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.

[171]  M. Pillai,et al.  The stem cell code in oral epithelial tumorigenesis: 'the cancer stem cell shift hypothesis'. , 2010, Biochimica et biophysica acta.

[172]  Jing Yang,et al.  Visualizing extravasation dynamics of metastatic tumor cells , 2010, Journal of Cell Science.